Kirsten Moysich, PhD, MS Kirsten Moysich, PhD, MS

Kirsten Moysich

PhD, MS

Special Interests:

Immune function in the etiology and prognosis of cancer Molecular epidemiology Ovarian cancer, multiple myeloma and breast cancer

About Kirsten Moysich

Biography:

Dr. Moysich joined the staff of Roswell Park Comprehensive Cancer Center in 1998 and was appointed as Professor of Oncology and Full Member in the Department of Cancer Prevention and Control in 2009. She also serves as Professor and Academic Program Chair, Department of Cancer Pathology and Prevention and Professor, Department of Social and Preventive Medicine at the State University of New York at Buffalo. Dr. Moysich earned her doctoral degree in Epidemiology and Community Health and completed a postdoctoral fellowship in Social and Preventative Medicine at SUNY Buffalo.

Dr. Moysich has authored or co-authored more than 200 peer-reviewed journal publications. She is an ad-hoc reviewer for more than 30 journals and has participated in over 20 study sections since 2003. She is currently a permanent member of the National Cancer Institute Subcommittee J – Population and Patient-Orientated Training Review Group.  Dr. Moysich serves on numerous national and international advisory committees, including the Scientific Advisory Board for the Sister Study, National Institute of Environmental Health Sciences and the Scientific Advisory Board, Exposure and Human Health Committee, U.S. Environmental Protection Agency.

Dr. Moysich maintains an active teaching and mentoring schedule. She has served as the primary or co-mentor of over 30 MS or PhD students since 2000. Dr. Moysich has taught PTR 525 Cancer Epidemiology since 1998 and gives frequent guest lectures at Roswell Park Comprehensive Cancer Center and the State University of New York at Buffalo. She is also very involved with the cancer advocacy community and has given numerous local and national presentations on a variety of cancer related topics. Dr. Moysich serves on the faculty of the National Breast Cancer Coalition’s Project Lead program and as a Member of the Healthcare Advisory Council of Gilda’s Club Western New York.

In addition to her other research and academic pursuits, Dr. Moysich hosts an annual lecture series in honor of Dr. Julie Baker, a talented and much loved and respected student, physician, and researcher who did her medical and epidemiology training at UB and Roswell Park. Watch the presentation of the 2015 Dr. Julie Baker Memorial Lecture.

Positions

Roswell Park Comprehensive Cancer Center
  • Distinguished Professor of Oncology
  • Department of Cancer Prevention and Control
  • Professor, Department of Immunology
State University of New York at Buffalo
  • Professor and Academic Program Chair, Department of Cancer Pathology and Prevention
  • Research Professor, Department of Social and Preventive Medicine

Background

Education and Training:

  • PhD - Epidemiology and Community Health, State University of New York at Buffalo, Buffalo, NY

Fellowship:

  • Postdoctoral Fellowship - Social and Preventative Medicine, State University of New York at Buffalo, Buffalo, NY

Professional Memberships:

  • American Association for Cancer Research
  • American College of Epidemiology
  • International Society for Environmental Epidemiology
  • Molecular Epidemiology Group
  • Women in Cancer Research

Research

Research Overview:

Dr. Moysich’s research interests focus on the role of regulatory T cells (or Treg cells) in the etiology and prognosis of human cancers. Treg cells are a unique subset of T cell with immunosuppressive properties, which appear to be lower in patients with various immune conditions and higher among cancer patients. However, many of the previous studies on the role of Treg cells and cancer were relatively small and had important methodological limitations. Dr. Moysich is applying rigorous epidemiological methods to gain a more definitive understanding on the association between Treg cells and cancer. She is also interested in the relationship between genes that influence Treg cell activity and cancer etiology and prognosis. Dr. Moysich currently holds funding to study Treg cells in the etiology and prognosis of breast cancer, ovarian cancer and multiple myeloma. More recently, Dr. Moysich has also focused her attention on the role of myeloid derived suppressor cells, another novel immunosuppressive cell population, in human carcinogenesis. Dr. Moysich is an active participant in the Ovarian Cancer Association Consortium (OCAC), a large international group of ovarian cancer scientists aiming to uncovering genetic and environmental risk and prognostic factors for ovarian cancer. Her affiliation with OCAC will allow her to study SNPs in genes relevant in the Treg cell and MDSC pathways in relation to ovarian cancer etiology and prognosis in a very large sample of patients and healthy controls. In addition to her work related to these immunosuppressive pathways, Dr. Moysich’s research program includes pharmacogenetic studies of acute leukemia and ovarian cancer. She is also interested in the effect of common exposures, such as aspirin use or coffee consumption, in the development of solid and hematological malignancies.


Publications

Full Publications list on PubMed
  • Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Berchuck A, Moorman PG, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Yang HP, Garcia-Closas M, Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Ziogas A, Brewster W, Anton-Culver H; Australian Ovarian Cancer Study Management Group; Australian Cancer Study (Ovarian Cancer), Pearce CL; Ovarian Cancer Association Consortium (OCAC). ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):245-50. doi: 10.1158/1055-9965.EPI-09-0729. PMID: 20056644; PMCID: PMC2863004.
  • Sellers TA, Blaakaer J, Kjaer SK, Hogdall E, Hogdall C, Ziogas A, Anton-Culver H, Rossing MA, Doherty JA, McGuire V, DiCioccio RA, Whittemore AS, Quaye L, Ramus SJ, Jacobs I, Berchuck A, Chenevix-Trench G, Schildkraut JM, Goodman MT, Cunningham JM, Gayther SA, Pike MC, Marks JR, Iversen ES, Pharoah PDP, Song H, Whiteman DC, Terry KL, Stram DO, Edwards RP, Moysich K, Cramer DW, Chanock S, Webb PM, Chen XQ, Beesley J, Fridley BL, Vierkant RA, Goode EL, Tsai Y-Y, Chang-Claude J, Garcia-Closas M, Yang H, Van Den Berg DJ, Wu AH, Pearce CL, Ness RB, Wilkens LR, Lurie G, Carney ME, Lissowska J, Green AC, Hein R, Wang-Gohrke S, Phelan CM.Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer epidemiology, biomarkers and prevention 2010; 19(2):600-604
  • Tang L, Zirpoli GR, Jayaprakash V, Reid ME, McCann SE, Nwogu CE, Zhang Y, Ambrosone CB, Moysich KB. Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study. BMC cancer 2010; 10 :162
  • Brasky TM, Shields PG, Trevisan M, Marian C, Kallakury BVS, Edge SB, Tao MH, Nie J, Ambrosone CB, Moysich KB, Bonner MR, Freudenheim JL. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control 2010; 21(9):1503-1512
  • Hampras SS, Ford L, Blanco JG, Chennamaneni R, Wetzler M, Singh PK, Zirpoli G, Baer MR, Weiss J, Sucheston L, Moysich KB. Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with acute myeloid leukemia. International journal of molecular epidemiology and genetics 2010; 1(3):201-207
  • Chenevix-Trench G, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Ramus SJ, Gayther SA, Pike MC, Wu AH, Stram DO, Pearce CL, Whitemore AS, Hogdall E, Kjaer SK, Hogdall C, Haviv I, Goode EL, Rider DN, Vierkant RA, Cunningham JM, Sellers TA, Phelan CM, Moorman PG, Iversen ES, Schildkraut JM, Berchuck A, Song H, Pharoah PD, Chanock SJ, Goodman MT, Doherty JA, Rossing MA, Webb PM, Gava N, de Fazio A, Spurdle AB, Duffy DL, Macgregor S, Chen X, Beesley J, Lurie G, Thompson PJ, Wilkens LR, Lissowska J, Yang H, Garcia-Closas M, Tworoger SS, Hankinson SE, Terry KL, Cramer DW, Wang-Gohrke S, Chang-Claude J, Moysich KB, Ness RB, Johnatty SE. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS genetics 2010; 6(7):e1001016
  • Goode EL, Pharoah PDP, Pearce CL, Palmieri RT, Ness RB, Moysich K, Moorman PG, Menon U, Lurie G, Kjaer SK, Ramus SJ, Song H, Stram DO, Sellers TA, Schildkraut JM, Wu AH, Wilkens LR, Whittemore AS, Wang-Gohrke S, Vierkant RA, Van Den Berg D, Tworoger SS, Hogdall E, Gentry-Maharaj A, Brar S, Berchuck A, Beesley J, Anton-Culver H, Kobel M, Webb PM, Rossing MA, McGuire V, Goodman MT, Carney ME, Chang-Claude J, Chenevix-Trench G, Gayther SA, Gates MA, Fridley BL, Fredericksen ZS, Easton DF, Doherty JA, DiCioccio RA, Cunningham JM, Cramer DW, Kelemen LE. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer epidemiology, biomarkers and prevention 2010; 19(7):1822-1830
  • Kesterson J, Weiss J, Rodabaugh K, Nowell S, Odunsi K, Zirpoli G, Grasela M, Sucheston L, Moysich K. An assessment of the concordance of pharmacogenetic polymorphisms between tumor and germline specimens in patients with ovarian cancer. Gynecologic oncology 2010; 116(3 Suppl. 1):348
  • Kuptsova-Clarkson N, Wetzler M, Blanco J, Ford L, Kopecky KJ, Zirpoli G, Sucheston LE, Baer MR, Weiss J, Ambrosone CB, Moysich KB. XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia. International journal of molecular epidemiology and genetics 2010;1(4):278-294
  • Moysich KB, Nesline M, Davis W, Wallace P, Grasela M, Hampras S, Chennamaneni R, Odunsi K. The influence of regulatory T cells on breast cancer risk and clinical characteristics. Proceedings of the American Association for Cancer Research Annual Meeting 2010; 51:1288
  • Peppone LJ, Reid ME, Moysich KB, Morrow GR, Jean-Pierre P, Mohile SG, Darling TV, Hyland A. The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer. Cancer Causes Control 2010; 21(8):1247-1255
  • Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE. Intake of cruciferous vegetables modifies bladder cancer survival. Cancer epidemiology, biomarkers and prevention 2010; 19(7):1806-1811
  • Hogdall C, Hillemanns P, Durst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doerk T, Antonenkova N, Bogdanova N, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Butzow R, Nevanlinna H, Leminen A, Doherty J, Chen C, Ekici AB, Chen X, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas M, Sellers T, Easton DF, Berchuck A, Chenevix-Trench G, Pharoah PDP, Thiel FC, Beckmann MW, Fasching PA, Rafnar T, Besenbacher S, Sulem P, Stefansson K, Birrer MJ, Terry KL, Hernandez D, Cramer DW, Vergote I, Amant F, Lambrechts D, Despierre E, Gayther SA, Bolton KL, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Wu AH, Pearce CL, Stram DO, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai Y-Y, Weidhaas J, Paik D, Van Den Berg DJ, Campbell I, Gore ME, Tomlinson I, Palmieri RT, Moorman PG, Schildkraut J, Iversen ES, Phelan C, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Kruger-Kjaer S, Blaeker J, Houlston R, Van Altena AM, Aben KKH, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Le ND, Cook LS, Kelemen LE, Brook-Wilson A, Massuger LFAG, Kiemeney LA, Hogdall E. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature genetics 2010; 42(10):880-884
  • Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dörk T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KK, Massuger LF, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC; Wellcome Trust Case-Control Consortium, Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium (OCAC), Chen X, Ekici AB, Thiel FC, Beckmann MW, Yang H, Wentzensen N, Lissowska J, Fasching PA, Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, Dürst M, Antonenkova N, Bogdanova N, Leminen A, Butzow R, Heikkinen T, Stefansson K, Sulem P, Besenbacher S, Sellers TA, Gayther SA, Pharoah PD; Ovarian Cancer Association Consortium (OCAC). A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010 Oct;42(10):874-9. doi: 10.1038/ng.668. Epub 2010 Sep 19. PMID: 20852632; PMCID: PMC3020231.
  • Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, Kjær SK, Hogdall E, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Schildkraut JM, Moorman PG, Palmieri RT, Ness RB, Moysich K, Cramer DW, Terry KL, Vitonis AF, Pike MC, Berchuck A, Pearce CL; Ovarian Cancer Association Consortium; Australian Cancer Study (Ovarian Cancer) (ACS); Australian Ovarian Cancer Study Group (AOCS). Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertil Steril. 2011 Jan;95(1):40-5. doi: 10.1016/j.fertnstert.2010.06.059. Epub 2010 Aug 17. PMID: 20719308; PMCID: PMC3176720.
  • Brasky TM, Shields PG, Trevisan M, Edge SB, Tao MH, Nie J, Ambrosone CB, Marian C, Ochs-Balcom HM, Moysich KB, Bonner MR, Freudenheim JL.Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast cancer research and treatment 2011; 126(1):157-165
  • Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Annals of epidemiology 2011; 21(3):188-196
  • Pichert G, Miron A, GEMO Study Collaborators, Fert-Ferrer S, Venat-Bouvet L, Collonge-Rame MA, Prieur F, Bignon YJ, Nogues C, Buys SS, Hopper JL, Ejlertsen B, Jonson L, Hansen TO, BCFR, Goldgar D, Terry MB, John EM, Daly MB, Lidereau R, Faivre L, Side LE, Rogers MT, Kennedy MJ, Porteous M, Morrison PJ, Brewer C, Hodgson S, Cole T, Donaldson A, Gregory H, Leroux D, Bonadona V, Barjhoux L, Mazoyer S, Castera L, Moncoutier V, Stoppa-Lyonnet D, Godwin A, Agnarsson BA, Offit K, de la Hoya M, Caldes T, Gadzicki D, Niederacher D, Kast K, Varon-Mateeva R, Deissler H, Arnold N, Nevanlinna H, Aittomaki K, Antoniou AC, Easton DF, Chenevix-Trench G, Holland H, Spurdle AB, kConFab Investigators, Soucy P, Simard J, Sutter C, Fiebig B, Janavicius R, Imyanitov EN, Casella C, Montagna M, Przybylo JA, Dutra-Clarke AV, Vijai J, Kirchhoff T, Blanco I, Lazaro C, Ruehl I, Meindl A, Wappenschmidt B, Schmutzler R, Beattie MS, Gross J, Karlan BY, Moysich KB, Consortium of Investigators of Modifiers of BRCA1/2, Ramus SJ, Glendon G, Andrulis IL, Mai PL, Greene MH, Radice P, Capra F, Gismondi V, Papi L, Ozcelik H, OCGN, Kristoffersson U, Olsson H, Caligo MA, Jensen UB, Cruger D, Kruse TA, Gerdes AM, Thomassen M, Ottini L, Allavena A, Healey S, McGuffog L, Chen X, Beesley J, Sinilnikova OM, Pharoah PD, Gayther SA, Kartsonaki C, Couch FJ, Wang X, Viel A, Barile M, Roversi G, Zaffaroni D, Peissel B, Manoukian S, Peterlongo P, Fredericksen Z, Lindblom A, Arver B, Asperen CJ, van Os TA, Ausems MG, Bodmer D, Vreeswijk MP, Tilanus-Linthorst MA, Verhoef S, Rookus MA, Blok MJ, Meijers-Heijboer HE, Evans DG, Dunning AM, Frost D, Oliver C, Cook M, Peock S, EMBRACE, HEBON, Hamann U, Benitez J, Jakubowska A, Domchek SM, Nathanson KL, Ding YC, Neuhausen SL, Borg A, Stenmark Askmalm M, Karlsson P, Lubinski J, Huzarski T, Tejada MI, Duran M, Osorio A, Debniak T, Cybulski C, Gorski B, Gronwald J, Byrski T, Eeles R.Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute 2011; 103(2):105-116
  • Jayaprakash V, Bogaards A, Frustino J, Gill SR, Wilson BC, Mang TS, Hutson AD, Marshall JR, Johnson T, Ramananda S, Moysich KB, Popat SR, Loree TR, Rigual NR, Merzianu M, Sullivan M, Reid ME. Autofluorescence-guided surveillance for oral cancer. Cancer prevention research (Philadelphia, Pa.)2009; 2(11):966-974
  • Johnatty SE, Pearce CL, Rossing M-A, Doherty J, Ness R, Moysich K, Van Den Berg D, Pike M, Wu AH, Anderson S, Vierkant RA, Rider DN, Goode EL, Webb PM, DeFazio A, Spurdle AB, Chen X, Beesley J, Chenevix-Trench G.Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin research and human genetics 2009; 12(3):269-275
  • McCann SE, Yeh M, Rodabaugh K, Moysich KB. Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk. International journal of cancer 2009; 124(7):1650-1653
  • Obermair A, Young B, Nevell D, Gard G, Ferrier A, Baron-Hay S, Bell D, Maidens J, Friedlander M, Nattress K, Beale P, Beith J, Horwood K, Cummings M, Crandon A, Russell P, Houghton R, Hamilton A, Dalrymple C, Carter J, Stewart J, Bonaventura T, Otton G, Simpson I, Robinson I, Ping Tong S, Constable J, Veitch A, Susil B, Rogers P, McNealage J, Schmidt T, Shirley H, Viduka S, Braye S, Proietto A, Robertson R, Mellon A, Zeps N, Glavinas L, Bilic S, Tran H, Maniolitas T, Leung Y, Rischin D, Phillips K, Bowes L, Fereday S, Traficante N, Robbie M, Laurie R, Hyde S, Waring P, Loughrey M, O'Callaghan N, McCartney A, Hammond I, Quinn M, Pyman J, Galloway S, Billson V, Haviv I, Murray B, Grant P, Allen D, Rome R, Healy T, Dodd T, Hall C, Davy M, Papadimos D, Ward B, Perrin L, Nicklin J, Pittman K, Henderson D, Hyde S, Brown B, Parker A, McIntosh R, Challis D, Blomfield P, Jayde V, Pierdes J, Miller J, Wyld D, Jobling T, Titus-Ernstoff L, Hogdall CK, Hogdall E, Kjaer SK, Jennison E, Edwards R, Moysich KB, Ness RB, Wilkens LR, Goode EL, Sellers TA, Vierkant RA, Vitonis AF, Terry KL, Cramer DW, Iversen ES, Moorman PG, Berchuck A, Schildkraut JM, Cunningham JC, Carney ME, Lurie G, Goodman MT, Edlund CK, Anderson AR, Gayther SA, Menon U, Gentry-Maharaj A, Ramus SJ, Van Den Berg DJ, Near AM, Wu AH, Chen X, Beesley J, DiCioccio RA, McGuire V, Whittemore AS, Rossing MA, Doherty JA, Chen C, Holt SK, Webb PM, Pearce CL, Healy D, Purdie D, Sadkowsky T, Harrap K, Moore S, Webb P, Green A, Wain G, Harnett P, Whiteman D, Alexander B, Ashover P, Mamers P, White J, Ranieri B, Martin K, Jackman L, Green L, Corrish T, Brown S, Jaworski R, Brand A, Sullivan H, Gertig D, Chenevix-Trench G, Galitovskiy V, Brewster W, Ziogas A, Anton-Culver H, Spurdle AB, Pharoah PDP, Vanden Bergh T, Camaris C, Crouch R, Stenlake A, Chiew YE, Hung J, DeFazio A, Robertson G, Marsden D, Hacker N, Edwards L, Song H. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British journal of cancer 2009; 100(2):412-420
  • Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, Mustian KM, Morrow GR. Examining the association between cigarette smoking and colorectal cancer using historical case-control data. Cancer epidemiology 2009; 33(3-4):182-188
  • Qian F, Old LJ, Shrikant P, Lele S, Moysich K, Cheney R, Liao J, Beck A, Frederick PJ, Ayyoub M, Valmori D, Matsuzaki J, Andrews C, Tario Jr JD, Mhawech-Fauceglia P, Wallace PK, Villella J, Odunsi K. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer research 2009; 69(13):5498-5504
  • Quaye L, Moysich KB, Hogdall C, Blaakaer J, Easton DF, Ponder BAJ, Jacobs IJ, Menon U, Whittemore AS, Kruger-Kjaer S, Pearce CL, Pharoah PDP, Ness RB, Rossing MA, Song H, Ramus SJ, Gentry-Maharaj A, Hogdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Gayther SA. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British journal of cancer 2009; 100(6):993-1001
  • Pharoah PDP, Berchuck A, Schildkraut JM, Anderson S, Cunningham JM, Vierkant RA, Goode EL, Moysich K, Ness RB, Carney ME, Thompson PJ, Iversen ES, Moorman PG, Gayther SA, Easton DF, Ponder BAJ, Brewster WR, Ziogas A, Anton-Culver H, Brinton L, Lissowska J, Chanock S, Garcia-Closas M, Lurie G, Goodman MT, Wang-Gohrke S, Blaakaer J, Hogdall C, McGuire V, Whittemore AS, Hogdall E, Pearce CL, Chenevix-Trench G, DiCioccio RA, Kjaer SK, Ramus SJ, Wu AH, Van Den Berg DJ, Chang-Claude J, Doherty JA, Rossing MA, Chen X, Beesley J, Webb PM, Jacobs IJ, Gentry-Maharaj A, Menon U, Stram DO, Song H. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human molecular genetics 2009; 18(12):2297-2304
  • McLaughlin J, Thiel FC, Terry KL, Tsai Y-Y, Tworoger SS, Van Den Berg DJ, Vierkant RA, Wang-Gohrke S, Webb PM, Stram DO, Southey M, Severi G, Medrek K, Moorman PG, Moysich K, Narod S, Phelan C, Pye C, Risch H, Runnebaum IB, Wilkens LR, Wu AH, Kjaer SK, Gronwald J, Garcia-Closas M, Fasching PA, Easton DF, Chenevix-Trench G, Berchuck A, Pharoah PDP, Menon U, Ness RB, Pearce CL, Yang H, Brewster W, Ziogas A, Houlston R, Tomlinson I, Whittemore AS, Rossing MA, Ponder BAJ, Gayther SA, McGuire V, Song H, Goodman MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J, Carney ME, Goode EL, Dork T, DiCioccio R, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, Chanock S, Chen Z, Hogdall C, Hogdall E, Iversen ES, Jacobs IJ, Jakubowska A, Li D, Lissowska J, Lubinski J, Hillemanns P, De Vivo I, Gore ME, Cunningham JM, Dicks E, Doherty JA, Durst M, Ekici AB, Fenstermacher D, Fridley BL, Giles G, Lurie G. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature genetics 2009; 41(9):996-1000
  • Yeh M, Moysich KB, Jayaprakash V, Rodabaugh KJ, Graham S, Brasure JR, McCann SE. Higher intakes of vegetables and vegetable-related nutrients are associated with lower endometrial cancer risks. Journal of nutrition 2009;139(2):317-322
  • Ramus SJ, Chen X, Ekici AB, Thiel FC, Beckmann MW, Rossing MA, Doherty JA, Wang-Gohrke S, Carney ME, Wilkens LR, Moysich KB, Beesley J, Gronwald J, Gayther SA, Pharoah PDP, Menon U, Whittemore AS, Pearce CL, Berchuck A, Chenevix-Trench G, Goodman MT, Chang-Claude J, Fasching PA, Ness RB, Lubinski J, Medrek K, McGuire V, Blaakaer J, Hogdall C, Christensen L, Kjaer SK, Hogdall E, Song H, Jones C, Dafou D, Quaye L, Wu AH, Van Den Berg DJ, Jakubowska A, Iversen ES, Moorman PG, Schildkraut JM, Tyrer J, Jacobs IJ, Sher T, Wozniak E, Gentry-Maharaj A, Pike MC, Notaridou M. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International journal of cancer 2011; 128(9):2063-2074
  • Akers S, Moysich K, Zhang W, Link P, Miller A, Lele S, Odunsi K, Karpf A.Association between global DNA hypomethylation in leukocytes and risk of ovarian cancer. Gynecologic oncology 2011; 121(1 Suppl.):100
  • Brasky TM, Shields PG, Trevisan M, Goerlitz DS, Marian C, Kallakury BV, Edge SB, Tao MH, Nie J, Ambrosone CB, Moysich KB, Bonner MR, Freudenheim JL. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 2011;22(7):965-975
  • Moysich KB, McCarthy P, Hall P. 25 years after Chernobyl: lessons for Japan?. Lancet oncology 2011; 12(5):416-418
  • Pearce CL, Medrek K, Jakubowska A, Lubinski J, Chenevix-Trench G, AOCS/ACS Study Group, Beesley J, Webb PM, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Edlund CK, Stram DO, Pike MC, Ness RB, Rossing MA, Gronwald J, Sieh W, McGuire V, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, Hogdall C, Whittemore AS, Wu AH. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human molecular genetics 2011;20(11):2263-2272
  • Johnatty SE, Lu Y, Lundvall L, Macgregor S, Marees T, Massuger LF, McLaughlin JR, Menon U, Montagna M, Moysich KB, Narod SA, Nathanson KL, Nedergaard L, Ness RB, Levine DA, Leunen K, Karlan BY, Kauff ND, Kaye SB, Chenevix-Trench G, kConFab Investigators and the Consortium of Investigators of Modifiers of BRCA1/2, Kelemen LE, Kiemeney LA, Kjaer SK, Lambrechts D, Lapolla JP, Lazaro C, Le ND, Leminen A, Nevanlinna H, Nickels S, Terry KL, Tsai YY, van Altena AM, Vergote I, Vierkant RA, Vitonis AF, Walsh C, Wang-Gohrke S, Wappenschmidt B, Wu AH, Ziogas A, Berchuck A, Risch HA, SWE-BRCA Investigators, Lindblom A, Osorio A, Paul J, Pearce CL, Phelan CM, Pike MC, Radice P, Rossing MA, Schildkraut JM, Sellers TA, Singer CF, Song H, Stram DO, Sutphen R, Ovarian Cancer Association Consortium, Pharoah PD, Brooks-Wilson A, Brown R, Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Chen YA, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Despierre E, Brewster W, Bolton KL, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, BCFR Investigators, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Doherty JA, Dork T, Godwin AK, Goode EL, Goodman MT, Gross J, Hansen TV, Harnett P, Rookus M, HEBON Investigators, Heikkinen T, Hein R, Hogdall C, Hogdall E, Iversen ES, Gentry-Maharaj A, GEMO Study Collaborators, Durst M, Eccles DM, Ekici AB, Easton D, EMBRACE Investigators, Fasching PA, de Fazio A, Fenstermacher DA, Flanagan JM, Fridley BL, Friedman E, Gao B, Sinilnikova O, Jakubowska A.The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing. Clinical cancer research 2011; 17(11):3742-3750
  • Beehler GP, Valdismarsdottir H, Havenaar J, Bromet E, Zevon M, Chegerov V, Pryshchepava A, Chegerova T, Falkner K, Baker JA, Moysich KB. A multilevel analysis of long-term psychological distress among Belarusians affected by the Chernobyl disaster. Public health 2008; 122(11):1239-1249
  • Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutrition and cancer 2008; 60(3):331-341
  • Heavey EJ, Moysich KB, Hyland A, Druschel CM, Sill MW. Differences in pregnancy desire among pregnant female adolescents at a state-funded family planning clinic. Journal of midwifery and women's health 2008; 53(2):130-137
  • Heavey EJ, Moysich KB, Hyland A, Druschel CM, Sill MW. Female adolescents' perceptions of male partners' pregnancy desire. Journal of midwifery and women's health 2008; 53(4):338-344
  • Heavey EJ, Moysich KB, Hyland A, Druschet CM, Sill MW. Differences in contraceptive choice among female adolescents at a state-funded family planning clinic. Journal of midwifery and women's health 2008; 53(1):45-52
  • Jayaprakash V, Natarajan KK, Moysich KB, Rigual NR, Ramnath N, Natarajan N, Reid ME. Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occupational and environmental medicine 2008;65(10):647-654
  • Padmanabhan A, Baker JA, Zirpoli G, Sait SN, Ford LA, Moysich KB, Baer MR.Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members. Leukemia research 2008; 32(12):1820-1823
  • Pearce CL, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA, Song H, Stram DO, Terry KL, Webb PM, Whiteman DC, Whittemore AS, Zheng W, Pharoah PD, Chenevix-Trench G, Pike MC, Schildkraut J, Berchuck A, Modugno F, McGuire V, Lissowska J, Wu AH, Gayther SA, Bale AE, Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Ovarian Cancer Association Consortium. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. British journal of cancer 2008; 98(2):282-288
  • Peppone LJ, Mahoney MC, Cummings KM, Michalek AM, Reid ME, Moysich KB, Hyland A. Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening. Journal of cancer research and clinical oncology 2008; 134(7):743-751
  • Ovarian Cancer Association Consortium, Edwards RP, Moysich KB, Ness RB, Blaakaer J, Hogdall C, Hogdall E, Kjaer SK, Liebow M, Cunningham JM, Schildkraut JM, Carney ME, Lurie G, Goodman MT, Goode EL, Chenevix-Trench G, Beesley J, Chen X, Webb PM, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Chang-Claude J, Kropp S, Wang-Gohrke S, Moorman PG, Berchuck A, Dicioccio RA, Gayther SA, Gentry-Maharaj A, Menon U, Pearce CL, Wu AH, Van Den Berg DJ, Pike MC, Johnatty SE, Vierkant RA, McGuire V, Whittemore AS, Song H, Hankinson SE, Tworoger SS, Cramer DW, Terry KL, Brinton L, Lissowska J, Chanock S, Garcia-Closas M, Pharoah PD, Easton DF, Ramus SJ. Consortium analysis of 7 candidate SNPs for ovarian cancer. International journal of cancer 2008; 123(2):380-388
  • Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA,Moysich KB. Consumption of black tea or coffee and risk of ovarian cancer. International journal of gynecological cancer 2007; 17(1):50-54
  • Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA.Environmental pollutants and breast cancer: epidemiologic studies. Cancer 2007; 109(12 Suppl.):2667-2711
  • Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S.Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?. Cancer 2007; 109(12 Suppl.):2627-2634
  • Ovarian Cancer Association Consortium, Marks JR, Iversen ES, Pike MC, Wu AH, Sellers TA, Cunningham JM, Couch FJ, Goode EL, Moysich KB, Garcia-Closas M, Brinton L, Lissowska J, Pharoah PD, Berchuck A, Chenevix-Trench G, Pearce CL, Schildkraut J, Ponder BA, Jacobs I, Easton DF, Peplonska B, Edwards RP, Ness RB, Hogdall C, Hogdall E, Shadforth D, Tyrer J, Quaye L, Whittemore AS, Kjaer SK, Ramus SJ, Song H, Blaeker J, DiCioccio R, McGuire V, Modugno F, Carney ME, Lurie G, Goodman MT, Australian Ovarian Cancer Study Group, Whiteman DC, Green AC, Beesley J, Webb PM, Gayther SA.Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer research 2007;67(7):3027-3035
  • Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: a review of the prospective observational studies. Cancer 2007; 109(12 Suppl.):2712-2749
  • Moysich KB, ipd_4, Beehler GP, Marshall JR, Menezes RJ, Baker JA, Weiss JR, Chanan-Khan A. Regular analgesic use and risk of multiple myeloma. Leukemia research 2007; 31(4):547-551
  • Menezes RJ, Salgia R, Moysich KB, Jayaprakash V, Johnson CS, Loewen G, Tretiakova M, Husain A, Cheney RT, Reid ME. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer epidemiology, biomarkers and prevention 2008; 17(5):1104-1110
  • Moysich KB, Baker JA, Menezes RJ, Jayaprakash V, Rodabaugh KJ, Odunsi K, Beehler GP, McCann SE, Villella JA. Usual adult body mass index is not predictive of ovarian cancer survival. Cancer epidemiology, biomarkers and prevention 2007; 16(3):626-628
  • Moysich KB, Beehler GP, Zirpoli G, Choi JY, Baker JA. Use of common medications and breast cancer risk. Cancer epidemiology, biomarkers and prevention 2008; 17(7):1564-1595
  • Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE. Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer epidemiology, biomarkers and prevention 2008;17(4):938-944
  • Weiss JR, Baer MR, Ambrosone CB, Blanco JG, Hutson A, Ford LA, Moysich KB. Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia. Cancer epidemiology, biomarkers and prevention 2007; 16(5):1038-1041
  • Huang RS, Fridley BL, Hogdall E, Kjaer SK, Jensen A, Moysich KB, Grasela M, Odunsi K, Brown R, Paul J, Lambrechts D, Despierre E, Vergote I, Gross J, Karlan BY, DeFazio A, Chenevix-Trench G, Vierkant RA, Goode EL, Johnatty SE, Gamazon ER, Im HK, Ziliak D, Duan S, Zhang W, Kistner EO, Chen P, Beesley J, Mi S, O'Donnell PH, Fraiman YS, Das S, Cox NJ, Lu Y, MacGregor S, Dolan ME. Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clinical cancer research 2011; 17(16):5490-5500
  • Darcy KM, Tian C, Ambrosone CB, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, DeLoia JA. A Gynecologic Oncology Group study of associations between polymorphisms in ABC transporter genes (ABCB1, ABCC2, and ABCG2) and outcome in advanced stage epithelial ovarian cancer treated with platinum and taxane chemotherapy. Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #5567
  • Krivak TC, Tian C, DeLoia J, Darcy K, Armstrong D, Gallion HH, Davis W, Zhao H, Moysich KB, Arnbrosone CB. BRCA1/BRCA2 polymorphisms and prognosis in women with optimally resected stage III epithelial ovarian cancer treated on GOG protocol 172: A Gynecologic Oncology Group study. Gynecologic oncology 2009; 112(2 Suppl. 1):16
  • Kuptsova-Clarkson N, Ambrosone C, Weiss J, Baer MR, Sucheston L, Zirpoli G, Kopecky K, Ford LA, Blanco J, Wetzler M, Moysich K. XPD DNA Nucleotide Excision Repair (NER) Gene Polymorphisms Associated with DNA Repair Deficiency May Predict Better Treatment Outcomes in Secondary Acute Myeloid Leukemia (AML). Blood 2009; 114(22):75
  • Moysich KB, Ness R, Zirpoli G, Modugno F, Rodabaugh K, Baker JA, Odunsi K. Genetic variability in regulatory T (Treg) cell function in ovarian carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 2008; 49:586-587
  • Moysich KB, Weiss J, Baker J, Davis W, Carter L, Odunsi K. High concordance between pharmacogenetic analysis of tumor and blood samples from patients with ovarian cancer. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:812
  • Odunsi K, Qian F, Villella J, Mhawech-Fauceglia P, Andrews C, Matsuzaki J, Frederick PJ, Cheney R, Moysich K, Lele S, Shrikant P, Old LJ. Tryptophan degradation by indoleamine 2,3-dioxygenase promotes preferential accumulation of CD4(+)CD25(high)FOXP3(+) regulatory T cells in human ovarian cancer. Gynecologic oncology 2008; 108(3 Suppl. 1):338
  • Weiss J, Baer M, Ambrosone CB, Blanco J, Ford L, Hutson A, Moysich KB.Polymorphisms in the glutathione S-transferase genes and treatment outcomes in acute myeloid leukemia. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:809
  • Marimuthu SP, Vijayaragavan P, Moysich KB, Jayaprakash V. Diabetes mellitus and gastric carcinoma: Is there an association?. Journal of carcinogenesis 2011; 10 :30
  • Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, Glendon G, Selander T, Weerasooriya N, Thomassen M, Gerdes A-M, Caligo MA, Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg A, Karlsson P, Askmalm MS, Bustinza GB, Nathanson KL, Domchek SM, Rebbeck TR, Benitez J, Hamann U, Rookus MA, van den Ouweland AMW, Ausems MGEM, Aalfs CM, van Asperen CJ, Devilee P, Gille HJJP, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard L, Paterson J, Eason J, Godwin AK, Remon M-A, Moncoutier V, Gauthier-Villars M, Lasset C, Giraud S, Hardouin A, Berthet P, Sobol H, Eisinger F, de Paillerets BB, Caron O, Delnatte C, Goldgar D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB, Singer CF, Dressler A-C, Tea M-K, Hansen TVO, Johannsson O, Piedmonte M, Rodriguez GC, Basil JB, Blank S, Toland AE, Montagna M, Isaacs C, Blanco I, Gayther SA, Moysich KB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Ding YC, Couch FJ, Wang X, Peterlongo P, Manoukian S, Bernard L, Radice P, Easton DF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D, Mazoyer S, Sinilnikova OM, Karlsson P, Nordling M, Bergman A, Einbeigi Z, Stenmark-Askmalm M, Liedgren S, Borg A, Loman N, Olsson H, Kristoffersson U, Soller M, Jernstrom H, Harbst K, Henriksson K, Lindblom A, Arver B, von Wachenfeldt A, Liljegren A, Barbany-Bustinza G, Rantala J, Melin B, Gronberg H, Stattin E-L, Emanuelsson M, Ehrencrona H, Brandell RR, Dahl N, Hogervorst FBL, Verhoef S, Verheus M, van't Veer LJ, van Leeuwen FE, Rookus MA, Collee M, van den Ouweland AMW, Jager A, Hooning MJ, Tilanus-Linthorst MMA, Seynaeve C, van Asperen CJ, Wijnen JT, Vreeswijk MP, Tollenaar RA, Devilee P, Ligtenberg MJ, Hoogerbrugge N, Ausems MG, van der Luijt RB, Aalfs CM, van Os TA, Gille JJP, Waisfisz Q, Meijers-Heijboer HEJ, Gomez-Garcia EB, van Roozendaal CE, Blok MJ, Caanen B, Oosterwijk JC, van der Hout AH, Mourits MJ, Vasen HF, Peock S, Cook M, Frost D, Platte R, Miedzybrodzka Z, Gregory H, Morrison P, Jeffers L, Cole T, Ong K-R, Hoffman J, Donaldson A, James M, Paterson J, Downing S, Taylor A, Murray A, Rogers MT, McCann E, Kennedy MJ, Barton D, Porteous M, Drummond S, Brewer C, Kivuva E, Searle A, Goodman S, Hill K, Davidson R, Murday V, Bradshaw N, Snadden L, Longmuir M, Watt C, Gibson S, Haque E, Tobias E, Duncan A, Izatt L, Jacobs C, Langman C, Whaite A, Dorkins H, Barwell J, Adlard J, Chu C, Miller J, Ellis I, Houghton C, Evans DG, Lalloo F, Taylor J, Side L, Male A, Berlin C, Eason J. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human molecular genetics 2011;20(23):4732-4747
  • Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Caligo MA, Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg Å, Karlsson P, Askmalm MS, Bustinza GB, SWE-BRCA Collaborators, Nathanson KL, Domchek SM, Rebbeck TR, Benítez J, Hamann U, Rookus MA, van den Ouweland AM, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P, Gille HJ, HEBON, EMBRACE, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Paterson J, Eason J, Godwin AK, Remon MA, Moncoutier V, Gauthier-Villars M, Lasset C, Giraud S, Hardouin A, Berthet P, Sobol H, Eisinger F, Bressac de Paillerets B, Caron O, Delnatte C, GEMO Study Collaborators, Goldgar D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB, Breast Cancer Family Registry, Singer CF, Dressler AC, Tea MK, Hansen TV, Johannsson O, Piedmonte M, Rodriguez GC, Basil JB, Blank S, Toland AE, Montagna M, Isaacs C, Blanco I, Gayther SA, Moysich KB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Ding YC, Couch FJ, Wang X, Peterlongo P, Manoukian S, Bernard L, Radice P, Easton DF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D, Mazoyer S, Sinilnikova OM, Consortium of Investigators of Modifiers of BRCA1/2. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human molecular genetics 2011; 20(23):4732-4747
  • Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benitez J, Garcia MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans DG, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ESK, Lazaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song H, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg A, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PDP. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA: the journal of the American Medical Association 2012; 307(4):382-390
  • Lo-Ciganic W-H, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB.Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology (Cambridge, Mass.) 2012; 23(2):311-319
  • Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, HEBON, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, EMBRACE, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schonbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L, GEMO Study Collaborators, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Canadas C, Heikkinen T, Heikkila P, Aittomaki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S, kConFab Investigators, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, SWE-BRCA Collaborators, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC, Moysich K, Consortium of Investigators of Modifiers of BRCA1/2. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer epidemiology, biomarkers and prevention 2012; 21(1):134-147
  • Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, Janavicius R, Hansen TV, Nielsen FC, Ejlertsen B, Osorio A, Munoz-Repeto I, Duran M, Godino J, Pertesi M, Benitez J, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Bonanni B, Viel A, Pasini B, Papi L, Ottini L, Savarese A, Bernard L, Radice P, Hamann U, Verheus M, Meijers-Heijboer HEJ, Wijnen J, Gomez Garcia EB, Nelen MR, Kets CM, Seynaeve C, Tilanus-Linthorst MMA, van der Luijt RB, Os TV, Rookus M, Frost D, Jones JL, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Cook J, Donaldson A, Dorkins H, Gregory H, Eason J, Houghton C, Barwell J, Side LE, McCann E, Murray A, Peock S, Godwin AK, Schmutzler RK, Rhiem K, Engel C, Meindl A, Ruehl I, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Kast K, Preisler-Adams S, Varon-Mateeva R, Schoenbuchner I, Fiebig B, Heinritz W, Schafer D, Gevensleben H, Caux-Moncoutier V, Fassy-Colcombet M, Cornelis F, Mazoyer S, Leone M, Boutry-Kryza N, Hardouin A, Berthet P, Muller D, Fricker J-P, Mortemousque I, Pujol P, Coupier I, Lebrun M, Kientz C, Longy M, Sevenet N, Stoppa-Lyonnet D, Isaacs C, Caldes T, de la Hoya M, Heikkinen T, Aittomaki K, Blanco I, Lazaro C, Barkardottir RB, Soucy P, Dumont M, Simard J, Montagna M, Tognazzo S, D'Andrea E, Fox S, Yan M, Rebbeck T, Olopade OI, Weitzel JN, Lynch HT, Ganz PA, Tomlinson GE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet M, Bhatia J, Kauff N, Singer CF, Tea M-K, gschwantler-kaulich D, Fink-Retter A, Mai PL, Greene MH, Imyanitov E, O'Malley FP, Ozcelik H, Glendon G, Toland AE, Gerdes A-M, Thomassen M, Kruse TA, Jensen UB, Skytte A-B, Caligo MA, Soller M, Henriksson K, Wachenfeldt VA, Arver B, Stenmark-Askmalm M, Karlsson P, Ding YC, Neuhausen SL, Beattie M, Pharoah PDP, Moysich KB, Nathanson KL, Karlan BY, Gross J, John EM, Daly MB, Buys SM, Southey MC, Hopper JL, Terry MB, Chung W, Miron AF, Goldgar D, Chenevix-Trench G, Easton DF, Andrulis IL, Antoniou AC. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast cancer research: BCR 2011; 13(6):R110
  • Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, Deloia JA. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecologic oncology 2012; 124(3):575-581
  • Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Carney ME, Palmieri RT, Wu AH, Pike MC, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Whittemore AS, McGuire V, Sieh W, Pharoah PD, Song H, Gronwald J, Jakubowska A, Cybulski C, Lubinski J, Schildkraut JM, Berchuck A, Kruger Kjaer S, Hogdall E, Fasching PA, Beckmann MW, Ekici AB, Hein A, Chenevix-Trench G, Webb PM, Beesley J, Australian Ovarian Cancer Study Group, Australian Cancer Study Group, Goodman MT, Moysich K, DiCioccio R, Grasela MT, Ovarian Cancer Association Consortium. Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PloS one 2011; 6(6):e20703
  • Bolton KL, Goh C, Ramus S, Goldgar D, Benitez J, Osorio A, Easton D, Peock S, Godwin A, Kwong A, Blanco I, kConFab Investigators, Goode E, Greene M, Loud J, Mai P, Toland A, Gore M, Olsson H, Neuhausen S, Moysich K, Beattie M, Sucheston L, Montagna M, Despierre E, Lambrechts D, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Antoniou A, Pharoah P. Genetic heterogeneity of ovarian cancer survival effects in BRCA1/2 germline mutations: a large, multi-center study. Proceedings of the American Association for Cancer Research Annual Meeting 2011; 52:Abstract #2752
  • Setiawan VW, Karageorgi S, Deming S, Anderson K, Bernstein L, Brinton L, Cai H, Cerhan JR, Chen C, Cozen W, Doherty JA, Freudenheim JL, Goodman MT, Horn-Ross P, Lissowska J, Lurie G, Mack T, Matsuno RK, McCann SE, Moysich K, Pike MC, Rebbeck TR, Robien K, Shu X-O, Spurdle AB, Strom BL, The Australian National Endometrial Cancer Study Group, Ursin G, Xiang Y-B, Webb PM, Weiss NS, Wentzensen N, Yang HP, De Vivo I. Age at last birth and endometrial cancer risk: Pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Proceedings of the American Association for Cancer Research Annual Meeting 2011; 52:Abstract #1900
  • Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, Brewster W, Anton-Culver H, Gentry-Maharaj A, Ramus SJ, Anderson AR, Brueggmann D, Fasching PA, Gayther SA, Huntsman DG, Menon U, Ness RB, Pike MC, Risch H, Wu AH, Berchuck A. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet oncology 2012; 13(4):385-394
  • Bole C, Jayaprakash V, Platek M, Reid ME, Sullivan M, Loree T, Rigual N, Popat S, Moysich KB. Coffee and tea consumption and risk of head and neck cancers. American journal of epidemiology 2009; 169(Suppl. 11):S49
  • Choi J-Y, Laden F, Millikan R, Zirpoli G, Grasela M, Gammon M, Helzlsouer K, Teitelbaum S, Wolff M, Zheng T, Moysich K. Pooled analyses of polychlorinated biphenyls (PCBs) exposure and CYP1A1 genetic polymorphisms on breast cancer risk. Proceedings of the American Association for Cancer Research Annual Meeting 2009; 50:953 (Abstract #3941)
  • Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer epidemiology, biomarkers and prevention 2012; 21(8):1282-1292
  • Hampras SS, Nesline M, Wallace PK, Odunsi K, Furlani N, Davis W, Moysich KB. Predictors of immunosuppressive regulatory T lymphocytes in healthy women. Journal of cancer epidemiology 2012; 2012 :191090
  • Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV, Liang XL, Lissowska J, Lu LG, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De Vivo I. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. American journal of epidemiology 2012; 176(4):269-278